European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer Journal Article

  

Authors:	Lordick, F.; Ruers, T.; Aust, D. E.; Collette, L.; Downey, R. J.; Hajjam, M. E.; Flamen, P.; Haustermans, K.; Ilson, D.; Julié, C.; Krause, B. J.; Newiger, H.; Ott, K.; Roth, A.; Cutsem, E. V.; Weber, W. A.; Lutz, M. P.
Article Title:	European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Abstract:	Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining importance in guiding treatment of localised and metastatic gastrointestinal tumours. During a workshop organised by the European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group the most relevant research questions, methodological aspects and unmet clinical needs in this disease were discussed. Potential future trials were drafted. This paper reviews the lectures and discussions held during this workshop and summarises the action points for the further investigation of metabolic imaging to guide treatment in gastrointestinal tumours. © 2008 Elsevier Ltd. All rights reserved.
Keywords:	cancer survival; treatment outcome; treatment response; cancer surgery; histopathology; bevacizumab; cisplatin; erlotinib; fluorouracil; clinical trials as topic; capecitabine; cancer adjuvant therapy; neoadjuvant therapy; positron emission tomography; cancer diagnosis; diagnostic accuracy; preoperative evaluation; colorectal cancer; reproducibility; consensus; metastasis; diagnostic imaging; cetuximab; cancer research; panitumumab; digestive system cancer; gastrointestinal neoplasms; europe; standardization; liver metastasis; cancer regression; algorithm; early diagnosis; quantitative analysis; fluorodeoxyglucose f 18; positron-emission tomography; response; organization; imaging; epirubicin; reliability; nuclear medicine; stomach adenocarcinoma; rectum cancer; esophagus carcinoma; multidetector computed tomography; matuzumab; gastrointestinal cancer
Journal Title:	European Journal of Cancer
Volume:	44
Issue:	13
ISSN:	0959-8049
Publisher:	Elsevier Inc.
Date Published:	2008-09-01
Start Page:	1807
End Page:	1819
Language:	English
DOI:	10.1016/j.ejca.2008.06.005
PUBMED:	18640028
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-49849083956&partnerID=40&md5=3929c0c6e2f4b447fa98550d862feed2
Notes:	--- - "Cited By (since 1996): 20" - "Export Date: 17 November 2011" - "CODEN: EJCAE" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/14849